The Queen Elizabeth Hospital is an acute care teaching hospital in the western suburbs of Adelaide, South Australia. It provides a range of health services, including inpatient, outpatient, surgical, emergency and mental health services.

During the past decade, Queen Elizabeth Hospital; Haematology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital; Haematology" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "BioNTech SE" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital; Haematology" are "Metastatic Colorectal Cancer" (2 trials), "Advanced Melanoma" (1 trials), "Diffuse Large B-Cell Lymphoma, Lymphoma Follicular" (1 trials), "Follicular Lymphoma" (1 trials) and "Hemoglobinuria, Paroxysmal" (1 trials). Many other conditions were trialed in "Queen Elizabeth Hospital; Haematology" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Hospital; Haematology" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Bendamustine" (2 trials), "Doxorubicin" (2 trials), "Rituximab" (2 trials) and "Vincristine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Hospital; Haematology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Queen Elizabeth Hospital; Haematology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Queen Elizabeth Hospital; Haematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Hospital; Haematology, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".